IDEXX Laboratories, Inc. (IDXX)
(Real Time Quote from BATS)
$521.22 USD
+4.28 (0.83%)
Updated Apr 14, 2021 09:58 AM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.55% |
| 3 | Hold | 10.24% |
| 4 | Sell | 5.98% |
| 5 | Strong Sell | 2.69% |
| S&P | 500 | 11.00% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
3-Hold of 5 3
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
| Value Score | A |
|---|---|
| Growth Score | A |
| Momentum Score | A |
| VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
D Value A Growth F Momentum C VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Industry / Sector Report
Industry : 17
Zacks Industry Rank More Info
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Zacks Sector Rank More Info
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.
A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
Zacks Sector Rank Education - Learn more about the Zacks Sector Rank
The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank
Premium Research: Industry Analysis
| Top Peers | Symbol | Zacks Rank |
|---|---|---|
| IDEXX Laboratories, Inc. | IDXX |  |
| Natus Medical Incorporated | NTUS | |
| Penumbra, Inc. | PEN | |
| Asensus Surgical, Inc. | ASXC | |
| CHF Solutions, Inc. | CHFS | |
| Cantel Medical Corp. | CMD | |
| ConforMIS, Inc. | CFMS | |
| ENDRA Life Sciences Inc. | NDRA | |
| Elekta AB | EKTAY | |
| Helius Medical Technologies, Inc. | HSDT | |
Recommendations and Estimates
| Company | Industry | SP500 | |
|---|---|---|---|
| Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.62 | 9.99 |
| Current Quarter Estimate | 1.72 | 4.83 | 43.00 |
| Year Ago Quarter Estimate | 1.29 | 1.85 | 19.50 |
| Next Quarter Estimate | 2.02 | 4.29 | 43.00 |
| Next Year Estimate | 8.74 | 20.54 | 200.00 |
Growth Rates
| Company | Industry | SP500 | |
|---|---|---|---|
| This Year | 12.52 | 23.60 | NA |
| Next Year | 15.76 | 23.00 | 14.74 |
| Last 5 Years | 24.60 | 2.60 | 8.00 |
| Next 5 Years | 15.80 | 16.40 | NA |
Financials
| Company | Industry | |
|---|---|---|
| Price/Earnings (TTM) | 77.04 | 70.61 |
| Price/Book (MRQ) | 69.68 | 5.60 |
| Price/Cash Flow (MRFY) | 65.06 | 27.96 |
| Dividend Yield | 0.00% | 0.00% |
| Net Profit Margin (TTM) | 21.49% | 4.72% |
| Return on Equity (TTM) | 159.90% | 12.13% |
| Debt to Equity (MRQ) | NA | 6.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.